Teva Pharmaceutical Industries Limited announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 3,910 million compared to USD 3,870 million a year ago. Operating income was USD 582 million compared to USD 173 million a year ago. Net income was USD 207 million compared to USD 140 million a year ago. Basic earnings per share from continuing operations was USD 0.19 compared to USD 0.13 a year ago. For the half year, sales was USD 7,892 million compared to USD 8,227 million a year ago. Operating income was USD 1,015 million compared to USD 364 million a year ago. Net income was USD 284 million compared to USD 209 million a year ago. Basic earnings per share from continuing operations was USD 0.26 compared to USD 0.19 a year ago.